Supplementary Tables 1-6 from Inactivating NF1 Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance

Autor: Nicholas C. Turner, Alistair Ring, Stephen R.D. Johnston, Alicia F.C. Okines, Marina Parton, Ashutosh Nerurkar, Peter Osin, Mitch Dowsett, Eugene F. Schuster, Elena Lopez-Knowles, Mike Hubank, Sabri Jamal, Lina Yuan, David Gonzalez De Castro, Brian A. Walker, Hannah Bye, Isaac Garcia-Murillas, Rosalind J. Cutts, Maria T. Herrera-Abreu, Ben O'Leary, Belinda Kingston, Monee K. Shamsher, Charlotte Fribbens, Javier Pascual, Paula Proszek, Alex Pearson
Rok vydání: 2023
DOI: 10.1158/1078-0432.22473269
Popis: Supplementary Table 1. Targets of The Breast NGS v1.0 capture panel. Supplementary Table 2. Gene list of NanoString nCounter{trade mark, serif} custom codeset. Supplementary Table 3. Gene list of Human Estrogen Receptor RT2 Profiler PCR Array (330231, PAHS-005ZA-24, Qiagen) Supplementary Table 4. Lines of treatment of patients with ESR1 and NF1 mutations. Supplementary Table 5. Disease free survival for mutated genes with incidence {greater than or equal to}5% presented by HR+/HER2-, HER2+ and TNBC subtype. Supplementary Table 6. Advanced overall survival for mutated genes with incidence {greater than or equal to}5% presented by HR+/HER2-, HER2+ and TNBC subtype
Databáze: OpenAIRE